← brief for 2026-09-22 · Slowing decline

Oral Semaglutide in Routine Clinical Practice: 24-Month Real-World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes.

Article C Peer reviewed Observational

Key takeaways

This study followed 232 adults with type 2 diabetes who took a daily pill called semaglutide. It looked at their health over 24 months. The study shows a link between the drug and changes in kidney health. It is not a controlled test, so it does not prove the drug caused the changes.

Who did this work

Baldassarre MPA · Di Dalmazi G · Carrieri F · Centorame G · Piacentino L · Coluzzi S · Formoso G

Source

Article · PubMed, the drug frontier · 2026 Sep 21
https://pubmed.ncbi.nlm.nih.gov/42768825/